PDB Short entry for 2Q6F HEADER HYDROLASE 05-JUN-07 2Q6F TITLE CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE TITLE 2 IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FRAGMENT; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~- COMPND 9 ((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3- COMPND 10 YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE; COMPND 11 CHAIN: D, C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFECTIOUS BRONCHITIS VIRUS; SOURCE 3 ORGANISM_TAXID: 11120; SOURCE 4 STRAIN: M41; SOURCE 5 GENE: M41 3C-LIKE PROTEASE GENE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-1; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 14 ORGANISM_TAXID: 32630 KEYWDS CORONAVIRUS; IBV; MAIN PROTEASE; 3C-LIKE PROTEINASE; MICHAEL ACCEPTOR KEYWDS 2 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.XUE,H.T.YANG,F.XUE,M.BARTLAM,Z.H.RAO REVDAT 6 15-NOV-23 2Q6F 1 LINK ATOM REVDAT 5 30-AUG-23 2Q6F 1 SEQADV LINK REVDAT 4 02-DEC-15 2Q6F 1 ATOM HETATM REMARK SEQRES REVDAT 4 2 1 VERSN REVDAT 3 24-FEB-09 2Q6F 1 VERSN REVDAT 2 25-MAR-08 2Q6F 1 JRNL REVDAT 1 12-FEB-08 2Q6F 0 JRNL AUTH X.XUE,H.YU,H.YANG,F.XUE,Z.WU,W.SHEN,J.LI,Z.ZHOU,Y.DING, JRNL AUTH 2 Q.ZHAO,X.C.ZHANG,M.LIAO,M.BARTLAM,Z.RAO JRNL TITL STRUCTURES OF TWO CORONAVIRUS MAIN PROTEASES: IMPLICATIONS JRNL TITL 2 FOR SUBSTRATE BINDING AND ANTIVIRAL DRUG DESIGN. JRNL REF J.VIROL. V. 82 2515 2008 JRNL REFN ISSN 0022-538X JRNL PMID 18094151 JRNL DOI 10.1128/JVI.02114-07 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.4 REMARK 3 NUMBER OF REFLECTIONS : 42003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4231 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 419 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Q6F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043207. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.22500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2Q6D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG10000, 0.1M HEPES PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER WITH ONE INHIBITOR REMARK 300 MOLECULE IN THE ACTIVE SITE OF EACH PROTOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -31.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: D, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 LYS A 214 REMARK 465 GLU A 215 REMARK 465 SER A 216 REMARK 465 SER A 217 REMARK 465 PHE A 218 REMARK 465 SER A 219 REMARK 465 GLN A 220 REMARK 465 GLY A 302 REMARK 465 GLY A 303 REMARK 465 VAL A 304 REMARK 465 ARG A 305 REMARK 465 LEU A 306 REMARK 465 GLN A 307 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 465 LYS B 214 REMARK 465 GLU B 215 REMARK 465 SER B 216 REMARK 465 SER B 217 REMARK 465 PHE B 218 REMARK 465 SER B 219 REMARK 465 GLN B 220 REMARK 465 GLY B 303 REMARK 465 VAL B 304 REMARK 465 ARG B 305 REMARK 465 LEU B 306 REMARK 465 GLN B 307 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 143 C20 PJE D 5 1.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 279 CB - CA - C ANGL. DEV. = -15.7 DEGREES REMARK 500 SER A 279 N - CA - CB ANGL. DEV. = 14.2 DEGREES REMARK 500 SER A 279 CA - C - N ANGL. DEV. = -19.3 DEGREES REMARK 500 ASP A 280 CB - CG - OD1 ANGL. DEV. = 8.9 DEGREES REMARK 500 ASP A 280 CB - CG - OD2 ANGL. DEV. = -8.4 DEGREES REMARK 500 ASP A 280 N - CA - C ANGL. DEV. = -18.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 41 1.61 -66.18 REMARK 500 PHE A 46 -167.63 -114.54 REMARK 500 ALA A 136 -156.32 -117.67 REMARK 500 ASN A 167 36.55 70.69 REMARK 500 ASP A 280 126.17 173.23 REMARK 500 LEU B 27 -169.49 -162.35 REMARK 500 HIS B 41 7.28 -65.89 REMARK 500 PHE B 46 -166.34 -119.90 REMARK 500 ALA B 136 -156.28 -118.83 REMARK 500 HIS B 162 -50.91 -120.08 REMARK 500 ASN B 167 45.41 70.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q6D RELATED DB: PDB REMARK 900 RELATED ID: 2Q6G RELATED DB: PDB DBREF 2Q6F A 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6F B 1 307 UNP Q3Y5H1 Q3Y5H1_9CORO 1 307 DBREF 2Q6F C 1 6 PDB 2Q6F 2Q6F 1 6 DBREF 2Q6F D 1 6 PDB 2Q6F 2Q6F 1 6 SEQADV 2Q6F GLY A -1 UNP Q3Y5H1 INSERTION SEQADV 2Q6F SER A 0 UNP Q3Y5H1 INSERTION SEQADV 2Q6F GLY B -1 UNP Q3Y5H1 INSERTION SEQADV 2Q6F SER B 0 UNP Q3Y5H1 INSERTION SEQRES 1 A 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 A 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 A 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 A 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 A 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 A 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 A 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 A 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 A 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 A 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 A 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 A 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 A 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 A 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 A 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 A 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 A 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 A 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 A 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 A 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 A 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 A 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 A 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 B 309 GLY SER SER GLY PHE LYS LYS LEU VAL SER PRO SER SER SEQRES 2 B 309 ALA VAL GLU LYS CYS ILE VAL SER VAL SER TYR ARG GLY SEQRES 3 B 309 ASN ASN LEU ASN GLY LEU TRP LEU GLY ASP SER ILE TYR SEQRES 4 B 309 CYS PRO ARG HIS VAL LEU GLY LYS PHE SER GLY ASP GLN SEQRES 5 B 309 TRP GLY ASP VAL LEU ASN LEU ALA ASN ASN HIS GLU PHE SEQRES 6 B 309 GLU VAL VAL THR GLN ASN GLY VAL THR LEU ASN VAL VAL SEQRES 7 B 309 SER ARG ARG LEU LYS GLY ALA VAL LEU ILE LEU GLN THR SEQRES 8 B 309 ALA VAL ALA ASN ALA GLU THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 309 LYS ALA ASN CYS GLY ASP SER PHE THR ILE ALA CYS SER SEQRES 10 B 309 TYR GLY GLY THR VAL ILE GLY LEU TYR PRO VAL THR MET SEQRES 11 B 309 ARG SER ASN GLY THR ILE ARG ALA SER PHE LEU ALA GLY SEQRES 12 B 309 ALA CYS GLY SER VAL GLY PHE ASN ILE GLU LYS GLY VAL SEQRES 13 B 309 VAL ASN PHE PHE TYR MET HIS HIS LEU GLU LEU PRO ASN SEQRES 14 B 309 ALA LEU HIS THR GLY THR ASP LEU MET GLY GLU PHE TYR SEQRES 15 B 309 GLY GLY TYR VAL ASP GLU GLU VAL ALA GLN ARG VAL PRO SEQRES 16 B 309 PRO ASP ASN LEU VAL THR ASN ASN ILE VAL ALA TRP LEU SEQRES 17 B 309 TYR ALA ALA ILE ILE SER VAL LYS GLU SER SER PHE SER SEQRES 18 B 309 GLN PRO LYS TRP LEU GLU SER THR THR VAL SER ILE GLU SEQRES 19 B 309 ASP TYR ASN ARG TRP ALA SER ASP ASN GLY PHE THR PRO SEQRES 20 B 309 PHE SER THR SER THR ALA ILE THR LYS LEU SER ALA ILE SEQRES 21 B 309 THR GLY VAL ASP VAL CYS LYS LEU LEU ARG THR ILE MET SEQRES 22 B 309 VAL LYS SER ALA GLN TRP GLY SER ASP PRO ILE LEU GLY SEQRES 23 B 309 GLN TYR ASN PHE GLU ASP GLU LEU THR PRO GLU SER VAL SEQRES 24 B 309 PHE ASN GLN VAL GLY GLY VAL ARG LEU GLN SEQRES 1 D 6 02J ALA VAL LEU PJE 010 SEQRES 1 C 6 02J ALA VAL LEU PJE 010 HET 02J D 1 8 HET PJE D 5 13 HET 010 D 6 8 HET 02J C 1 8 HET PJE C 5 13 HET 010 C 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 3 02J 2(C5 H5 N O3) FORMUL 3 PJE 2(C9 H14 N2 O3) FORMUL 3 010 2(C7 H8 O) FORMUL 5 HOH *419(H2 O) HELIX 1 1 SER A 10 LYS A 15 1 6 HELIX 2 2 HIS A 41 GLY A 44 5 4 HELIX 3 3 ASP A 49 ALA A 58 1 10 HELIX 4 4 ASN A 59 PHE A 63 5 5 HELIX 5 5 PHE A 179 TYR A 183 5 5 HELIX 6 6 VAL A 198 VAL A 213 1 16 HELIX 7 7 SER A 230 SER A 239 1 10 HELIX 8 8 SER A 249 GLY A 260 1 12 HELIX 9 9 ASP A 262 GLN A 276 1 15 HELIX 10 10 THR A 293 GLN A 300 1 8 HELIX 11 11 SER B 10 LYS B 15 1 6 HELIX 12 12 HIS B 41 GLY B 44 5 4 HELIX 13 13 ASP B 49 LEU B 57 1 9 HELIX 14 14 ASN B 59 PHE B 63 5 5 HELIX 15 15 PHE B 179 TYR B 183 5 5 HELIX 16 16 VAL B 198 VAL B 213 1 16 HELIX 17 17 SER B 230 ASN B 241 1 12 HELIX 18 18 SER B 249 GLY B 260 1 12 HELIX 19 19 ASP B 262 GLN B 276 1 15 HELIX 20 20 THR B 293 GLN B 300 1 8 SHEET 1 A 6 GLU A 64 VAL A 66 0 SHEET 2 A 6 ILE A 17 TYR A 22 -1 N SER A 21 O GLU A 64 SHEET 3 A 6 ASN A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 4 A 6 SER A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 5 A 6 VAL A 84 THR A 89 -1 O LEU A 85 N CYS A 38 SHEET 6 A 6 VAL A 75 LYS A 81 -1 N VAL A 76 O GLN A 88 SHEET 1 B 5 TYR A 99 PHE A 101 0 SHEET 2 B 5 VAL A 154 LEU A 165 1 O PHE A 157 N LYS A 100 SHEET 3 B 5 VAL A 146 GLU A 151 -1 N GLY A 147 O PHE A 158 SHEET 4 B 5 SER A 109 TYR A 116 -1 N THR A 111 O PHE A 148 SHEET 5 B 5 THR A 119 THR A 127 -1 O TYR A 124 N ILE A 112 SHEET 1 C 3 TYR A 99 PHE A 101 0 SHEET 2 C 3 VAL A 154 LEU A 165 1 O PHE A 157 N LYS A 100 SHEET 3 C 3 LEU A 169 THR A 173 -1 O LEU A 169 N LEU A 165 SHEET 1 D 7 THR B 72 LEU B 73 0 SHEET 2 D 7 GLU B 64 VAL B 66 -1 N VAL B 65 O LEU B 73 SHEET 3 D 7 ILE B 17 TYR B 22 -1 N SER B 21 O GLU B 64 SHEET 4 D 7 ASN B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 D 7 SER B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 D 7 VAL B 84 THR B 89 -1 O LEU B 85 N CYS B 38 SHEET 7 D 7 VAL B 75 LYS B 81 -1 N LYS B 81 O VAL B 84 SHEET 1 E 5 TYR B 99 PHE B 101 0 SHEET 2 E 5 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 E 5 VAL B 146 GLU B 151 -1 N ASN B 149 O ASN B 156 SHEET 4 E 5 SER B 109 TYR B 116 -1 N THR B 111 O PHE B 148 SHEET 5 E 5 THR B 119 THR B 127 -1 O TYR B 124 N ILE B 112 SHEET 1 F 3 TYR B 99 PHE B 101 0 SHEET 2 F 3 VAL B 154 LEU B 165 1 O PHE B 157 N LYS B 100 SHEET 3 F 3 LEU B 169 THR B 173 -1 O LEU B 169 N LEU B 165 LINK C 02J D 1 N ALA D 2 1555 1555 1.34 LINK C LEU D 4 N PJE D 5 1555 1555 1.33 LINK C PJE D 5 O 010 D 6 1555 1555 1.45 LINK C 02J C 1 N ALA C 2 1555 1555 1.34 LINK C LEU C 4 N PJE C 5 1555 1555 1.33 LINK C PJE C 5 O 010 C 6 1555 1555 1.47 SITE 1 AC1 16 HIS A 41 PHE A 138 ALA A 140 GLY A 141 SITE 2 AC1 16 CYS A 143 HIS A 161 HIS A 162 LEU A 163 SITE 3 AC1 16 GLU A 164 HIS A 170 GLU A 186 GLU A 187 SITE 4 AC1 16 VAL A 188 ALA A 189 SER A 256 GLY A 260 SITE 1 AC2 15 ASN B 25 ASN B 26 LEU B 27 HIS B 41 SITE 2 AC2 15 PHE B 138 GLY B 141 ALA B 142 CYS B 143 SITE 3 AC2 15 HIS B 161 HIS B 162 LEU B 163 GLU B 164 SITE 4 AC2 15 HIS B 170 GLU B 187 VAL B 188 CRYST1 53.175 54.502 66.719 111.06 104.31 91.33 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018806 0.000437 0.005357 0.00000 SCALE2 0.000000 0.018353 0.007467 0.00000 SCALE3 0.000000 0.000000 0.016700 0.00000